General Medicine
PREDICT Breast Cancer 5- and 10-year Survival (Bands)
PREDICT Breast (Wishart 2010; version 3, Grootes 2024) estimates overall survival after surgery for early invasive breast cancer and the absolute benefit of adjuvant treatments. It is a survival model with many inputs and cannot be scored here — use the official tool at breast.predict.cam.
References
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Drugs
- Cetuximab · Anti-EGFR Monoclonal Antibody — Head and Neck Cancer
- Cisplatin · Platinum Chemotherapy — Head and Neck Cancer
- Ianalumab (Anti-BAFF — Primary Sjögren's Syndrome) · Anti-BAFF Monoclonal Antibody (B-Cell Survival Factor Inhibitor)
- Dalteparin · Low Molecular Weight Heparin — VTE Treatment / Cancer-Associated Thrombosis
Pathways
- Falls Assessment in Older Adults · NICE CG161 2013
- Anaemia Investigation · BSH / NICE
- Lower Respiratory Tract Infection (Primary Care) · NICE NG138 / NICE antimicrobial guidance
- Hypertension Management · NICE NG136 2019
- Sepsis Screening and Sepsis Six · UK Sepsis Trust; NICE NG51; Surviving Sepsis Campaign 2021
- Unintentional Weight Loss Workup · NICE NG12; BSG
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.
